ArticlePloS one2020

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis.

Dong-Gon Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.